Odyssey Therapeutics Appoints William Roush, Ph.D., as EVP and Head of Small Molecule Research
Key Highlights Dr. William Roush appointed EVP and head of small molecule research. Focus on advancing small molecule…
Day: August 9, 2024
2 posts
Dragonfly Therapeutics Expands Leadership Team with New CFO Dr. Susan Altschuller
Key Highlights Dr. Susan Altschuller joins as Chief Financial Officer. Former CFO of Cerevel Therapeutics, ImmunoGen, and leadership roles at Alexion and Bioverativ. Extensive background…